chrisvoncsefalvay/vaers-outcomes huggingface dataset:
a metallic taste in the mouth; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 53 year-old female patient received bnt162b2 (BNT162B2), administration date 07Aug2021 (Lot number: EW0185, Expiration Date: Aug2021) at the age of 53 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Chronic fatigue syndrome", start date: 1991 (ongoing), notes: she has an autoimmune disorder; "Epstein-barr virus", start date: 1991 (ongoing), notes: she has an autoimmune disorder; "Cholesterol" (unspecified if ongoing); "all  four wisdom teeth pulled" (unspecified if ongoing), notes: prior to vaccines four wisdom teeth pulled and was on doxycycline, tylenol and ibuprofen. Family history included: "Cardiac issues/ Heart problems" (unspecified if ongoing); "Cholesterol issues/ High cholesterol" (unspecified if ongoing). Concomitant medication(s) included: PRAVASTATIN taken for hypercholesterolaemia (ongoing); COQ 10. Past drug history included: Doxycycline for all  four wisdom teeth pulled, notes: prior to vaccines four wisdom teeth pulled and was on doxycycline, tylenol and ibuprofen.; Tylenol for all  four wisdom teeth pulled, notes: prior to vaccines four wisdom teeth pulled and was on doxycycline, tylenol and ibuprofen.; Ibuprofen for all  four wisdom teeth pulled, notes: prior to vaccines four wisdom teeth pulled and was on doxycycline, tylenol and ibuprofen. The following information was reported: DYSGEUSIA (non-serious) with onset 07Aug2021, outcome "recovered" (07Aug2021), described as "a metallic taste in the mouth".  Additional Information: Caller states she takes Pravastatin prophylactically due to intense family history of high cholesterol and heart problems. She states it was an immediate metallic taste after the first shot and only lasted a few seconds. States this did not happen with the second dose of the vaccine. Vaccine was not Administered at (privacy) Facility. No Prior Vaccinations (within 4 weeks) prior to the first administration date of the suspect vaccine(s).  No follow-up attempts are possible. No further information is expected.
Site of administration on arm became very red and swollen and our son also had chills and a fever for several days.
she woke up every hour all night long; she couldn't lay on her arm; muscle pain in her arm; This spontaneous case was reported by a consumer and describes the occurrence of POOR QUALITY SLEEP (she woke up every hour all night long), LIMB DISCOMFORT (she couldn't lay on her arm) and MYALGIA (muscle pain in her arm) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 046B21A and 006B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 23-Apr-2021, the patient experienced POOR QUALITY SLEEP (she woke up every hour all night long), LIMB DISCOMFORT (she couldn't lay on her arm) and MYALGIA (muscle pain in her arm). At the time of the report, POOR QUALITY SLEEP (she woke up every hour all night long), LIMB DISCOMFORT (she couldn't lay on her arm) and MYALGIA (muscle pain in her arm) outcome was unknown.            No Concomitant medications were provided No Treatment information provided
SHORTNESS OF BREATH; DIZZINESS; KIDNEY PAIN; LOWER BACK PAIN; CHEST PAIN; ALMOST LETHARGIC; PAIN AT INJECTION SITE; VERY TIRED; NAUSEA; SLEPT THE MOMENT HE GOT VACCINE; This spontaneous report received from a consumer concerned a 44 year old male. The patient's height, and weight were not reported. The patient's past medical history included: adenoids removed, spleen removed, gallbladder removed, and tonsils removed, and concurrent conditions included: cigarettes smoker, and no alcohol use, and other pre-existing medical conditions included: The patient had no known allergies and no drug abuse or illicit drug usage. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A, and expiry: UNKNOWN) dose was not reported, administered on 23-AUG-2021 for prophylactic vaccination. No concomitant medications were reported. On 23-AUG-2021, the patient experienced slept the moment he got vaccine. On 24-AUG-2021, the patient experienced shortness of breath. On 24-AUG-2021, the patient experienced dizziness. On 24-AUG-2021, the patient experienced kidney pain. On 24-AUG-2021, the patient experienced lower back pain. On 24-AUG-2021, the patient experienced chest pain. On 24-AUG-2021, the patient experienced almost lethargic. On 24-AUG-2021, the patient experienced pain at injection site. On 24-AUG-2021, the patient experienced very tired. On 24-AUG-2021, the patient experienced nausea. Treatment medications (dates unspecified) included: naproxen sodium. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the dizziness, kidney pain, lower back pain, very tired, pain at injection site, chest pain, shortness of breath, almost lethargic, nausea and slept the moment he got vaccine was not reported. This report was non-serious.; Sender's Comments: V0: Medical assessment comment not required as per standard procedure as case assessed as non-serious.
ED to Hosp-Admission Discharged   9/21/2021 - 9/24/2021 (3 days)   Last attending ? Treatment team Pneumonia due to COVID-19 virus   Hospital Course This is a 77-year-old lady with history of asthma, hypertension, hyperlipidemia who came to Hospital emergency department with chest pain and shortness of breath.  She was admitted for work-up and she was recently diagnosed with COVID-19 infection on September 13.  Her repeat test was also positive.  CT scan of the chest showed bilateral pneumonia as well as pulmonary embolism.  Ultrasound scan of the leg shows left leg DVT.  She was initially treated with heparin infusion now changed to oral Eliquis which she needs to take 10 mg twice a day for 5 days then change to 5 mg twice a day.  She was also started on dexamethasone due to COVID-19 pneumonia.  Her oxygen saturation remained stable on room air.   On day of discharge her chest pain is better.  She still has trouble having deep breaths.  Denies any cough sputum.  Afebrile.  Denies any pain swelling in the legs.  Denies any nausea vomiting or abdominal pain.  No unusual bleeding.  No other new symptoms or acute event as per nursing staff
Got 5 shots in the morning, returned to school after getting shots. "Feel warm", "have a headache", & "not herself " in the afternoon. Had to sit aside for PE. Next day, still "disoriented", mixed up Wednesday, thought it's Thursday. TYLENOL given when having HA on the same date getting shots - 2x day after, still "not herself" 4 days after - increase sleep. To the doctor today 11/8/10.
Initial report received from a health care provider on 18/APR/2006.  A 35-year-old male patient with a medical history of allergies, had received a subcutaneous, right arm injection of YF-VAX, and an intramuscular, left deltoid injection of Hepatitis B vaccine.  Ten days post vaccination, the patient experienced facial numbness, numbness in the left arm and left hand and fever.  He was examined in an emergency room where a "CT scan and blood work were performed".  Results of the testing were not provided.  The patient had no illness at the time of vaccination and was taking Allegra for a medical history of allergies.  At the time of this report, the patient had recovered.  Follow-up information received on 01/MAY/2006.  The reporter received the case, and no additional relevant information was provided.
Information has been received from a pharmacist concerning a 60 year old female who received 2 doses of ZOSTAVAX. The pharmacist reported the first dose of ZOSTAVAX was administered on 04-DEC-2011 and the second dose of ZOSTAVAX (lot # 0364AE expiration 16-MAR-2013) was administered on 25-SEP-2012. No adverse events reported at this time. No other information was provided. Additional information has been requested.
This case was reported by a consumer via call center representative and described the occurrence of thrombocytopenia in a 42-year-old female patient who received FLUARIX. The patient's past medical history included alcoholism. Concurrent medical conditions included hepatitis C and lumbar disc degeneration (lumbar disc herniation, lumbar radiculopathy; many lumbar problems). Concomitant products included KLOR-CON, Mag oxide, PRILOSEC, buspirone, folic acid, gabapentin, ibuprofen, metoprolol and Multivitamin. On 18th November 2014 09:30, the patient received FLUARIX (intramuscular). In November 2014, an unknown time after receiving FLUARIX, the patient experienced thrombocytopenia and contusion. On 20th November 2014, the patient experienced upset stomach, respiratory tract congestion, sneezing, swollen glands, feeling cold, sweating and lethargy. On an unknown date, the patient experienced chapped skin and influenza. On an unknown date, the outcome of the thrombocytopenia, upset stomach, respiratory tract congestion, sneezing, swollen glands, chapped skin, feeling cold, sweating and contusion were not recovered/not resolved and the outcome of the influenza was recovered/resolved and the outcome of the lethargy was not recovered/not resolved. It was unknown if the reporter considered the thrombocytopenia, upset stomach, respiratory tract congestion, sneezing, swollen glands, chapped skin, influenza, feeling cold, sweating, lethargy and contusion to be related to FLUARIX. Additional information: Caller reports that she got a flu vaccine on 11/18/2014. She does not know what brand flu she received. Starting on Thursday she has been feeling sick with upset stomach, sweating and freezing, bad chest congestion, sneezing, lethargy and one gland is swollen and tender. The end of her nose has become chapped. She says it is still getting worse, especially the congestion and sneezing. She has been receiving the flu vaccine for 5 years now. She got the flu the second year she received the vaccine. She was recently diagnosed with thrombocytopenia, but it is not clear if the diagnosis was before or after this year's flu vaccine. She has a lot of bruising as a result of the thrombocytopenia. She is currently 42 years old.
This spontaneous report was received from a pharmacist via a company representative, concerning a female patient of an unknown age. The patient's medical history, concurrent conditions, concomitant medications, drug reactions or allergies were unknown by the reporter. On an unspecified date in 2014 (reported as "sometime in 2014"), the patient was vaccinated with PNEUMOVAX 23 from lot # M035104 (strength, expiration date, route of administration, and anatomical location were not reported), one dose was administered for prophylaxis. On an unspecified date after vaccination, the patient began experiencing cellulitis at the injection site as well as swelling and redness at the injection site too; and it lasted approximately four days then resolved (date unspecified). The patient sought medical attention by calling to the pharmacy and was advised to apply ice to the injection site to decrease the redness and swelling but it was unknown if the patient did it. It was unknown if laboratory diagnostics studies were performed. No product quality complaint (PQC) was involved. The causal relationship between the cellulitis, swelling and redness at the injection site with PNEUMOVAX 23 was not provided. This is one of several reports received from the same source.; Sender's Comments: US-009507513-1711USA006166: US-009507513-1711USA007675:
Body aches, headache, nausea, fatigue, soreness around injection site, chills, sweats
The above patient was vaccinated on 31MAR21 @ 1750.  Patient reported on 09APR21 that on 01APR21, the injection site (left deltoid) was sore, itchy and hardened.
Erythematous induration (walnut size) at site of injection, slowly resolving.
Information has been received from a healthcare worker concerning a 19 year old female with no drug allergies who on 28-JUL-2007, 30-SEP-2007 and 31-JAN-2008 was vaccinated in left arm with the first, second and third dose of GARDASIL (LOT# not reported), respectively. The patient reported right arm pain whenever it rained since the GARDASIL. She sought medical attention in the office and was reported as not recovered at the time of this report. Follow-up information has been received and it was reported that on 26-AUG-2009 during a routine physical, the female patient complained that her right arm hurts every time it rained, and "exactly where GARDASIL was given". All three doses of GARDASIL were given IM in her left deltoid, the first dose's lot was 656371/0181U, the second dose's lot was 658490/0802U and the third dose's lot was 658558/1061U. At the time of this report, the patient's outcome was unknown. Additional information has been requested.
He became nauseous, started sweating, felt like his heart would come out of his chest, ears ringing, dizzy, lost color and almost passed out.  It took the ER all day to get his rhythm under control and they even said they might have to put him under and shock him back into a normal rhythm.
On December 23, 2022, I woke up with a sore throat which was accompanied with white spots in the back of my throat. It persisted for eight to nine days, then went away. It was resistant against all medication. It came back in January and also in February. The time it came back in February it lasted for two to three weeks.
PATIENT WAS OBSERVED FOR 30 MINUTES FELT FINE. AFTER SHE LEFT THE FACILITY STARTED FEELING THROAT IRRITATION AND ITCHING.
Prior to these events I tested positive for Covid-19 antibodies in July of 2020. I believe I got covid coming home from a trip in January of 2020. Booster vaccine on 7/15/2022; pain in right calf 7/20/22; ultrasound on 7/27/2022, DVT; follow up on 8/10/2022, DVT resolved; day trip on 8/23/2022, chest pains and breathing difficulty; called for appointment on 8/24/2022, could not get appointment for a month; department recommended their immediate care clinic which I went to on 8/25/2022, PEs diagnosed in both lungs; began xarelto on 8/25/2022; A-fib diagnosed on 9/2/2022
Information has been received from a consumer who is a female who on 10OCT2003 was vaccinated with dose of pneumococcal 23v polysaccharide. In October 2003, the pt developed extensive arm swelling, redness and pain which lasted for three to four days. The reporter also mentioned three females who received a dose of pneumococcal 23v polysaccharide at the same time and experienced similar symptoms and men (our husbands) who received a dose of pneumococcal 23v polysaccharide and had minimal discomfort. Additional information has been requested.
I sat for 15 minutes in the pharmacy as they usually ask, after I left with in 20 minutes both  of my legs went numb and so because I have central nervous system disorder my left side was very painful so I started pounding my legs to make sure I can feel them, I was afraid I wasn't going to make it home because we live 35 Minutes away so when I got home I called MD and he advised me to monitor. The numbness didn't go away until June 5th, at around April on right thigh I also was having numbness and pain and that has nothing to due with my illness, the pain on my leg was really bad that I couldn't walk around my dog. I used CBD ointments and it did seem to help me some but that's when I had 3 MRI's because my neurologist wanted to make sure my  Lesion on my spine just to make sure it wasn't getting worse. He had increased my prednisone up to 10MG. when I got the MRI showed that there wasn't nothing bad showing on my spine.  He decided diagnoses was autoimmune response to the vaccine. so it really wasn't my NMO.
I was doing light yard work and felt discomfort in my chest. Went in the house to get hydrated and test my blood pressure and pulse. Rapid heart rate of 143. Monitored for 3 hours and was consistently 140-142. Called cardiologist who referred me to the Emergency Room at the hospital ER Administered Cardizen IV and returned to normal heart rate within 45 minutes. I have been experiencing foggy brain since the incident. I consider myself to be in perfect health and am very active.
bled (where he received the injection)/Blood was dripping from injection site; This is a spontaneous report from a contactable consumer (patient's wife) via a Pfizer-sponsored program. A male patient of an unspecified age received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot number was not reported), via an unspecified route of administration on 04Mar2021 as a single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient received the first dose of Pfizer-BioNTech COVID-19 Vaccine on 12Feb2021 for COVID-19 immunisation. Reporter stated she was calling on behalf of her husband who called her after the vaccination today and told her "he bled (where he received the injection), vaccinators seemed surprised". Then asked: "if you bleed then it is not intramuscular, right?". He wanted to know if his injection was IM or not IM; and what would happen to the efficacy if it was not administered intramuscularly. She was not sure vaccine went into muscle. Blood was dripping from injection site. The patient believes it wasn't inter muscular and wants to know if it's still effective and will he get the desired response. The outcome of the event was unknown.  Information about the Lot/batch number has been requested
Burning and itching of the vulva and white thick discharge from the vagina persisting now for 5 days. ObGYn doctor has treated it with baking soda baths and Clobetasol propionate. Not fully recovered
Pfizer vaccine was administered as the second dose vaccine instead of Moderna that was administered as first dose.
Donor received his immunization, from his statement noticed some discomfort to his left hand and seen. That there is some swelling approx 24 hrs since his shot. No other sign/symp. Dur. ob. swelling approx 24 hrs.
Patient called the next day and reported a spike in blood pressure that started at 1am and rapid heartbeat. Knowing that this is not a common side effect I advised patient to seek medical attention
Vaccine booster administered on 11/12/2021, expiration date was 11/07/2021. Mistook expiration date to be 11/17/2021. No adverse event or outcome to recipient.
they are very painful/ it was on the side where I got the vaccine; severe neck pain; gave me temperature; headache like for two days; This case was reported by a consumer via interactive digital media and described the occurrence of injection site pain in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Previously administered products included Shingles Vaccine with an associated reaction of injection site pain (1st dose was received on unknown date refer case US2023AMR003429).   On an unknown date, the patient received the 2nd dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced injection site pain, neck pain, fever and headache. Rechallenge with Shingles vaccine was positive. On an unknown date, the outcome of the injection site pain, neck pain and fever were unknown and the outcome of the headache was recovered/resolved.   It was unknown if the reporter considered the injection site pain, neck pain, fever and headache to be related to Shingles vaccine.     Linked case(s) involving the same patient:  US2023AMR003429   Additional Information: GSK Receipt Date: 09-JAN-2023 Reporter's Comments: This case was reported by a consumer via interactive digital media. The patient received two doses of Shingles vaccine. The patient had stated that they were very painful, gave him/her temperature, severe neck pain. The patient had stated that it was on the side where he/she got the vaccine and also the headache was like for two days, but he/she had asked that imagined that this was nothing as compared to suffering from shingles. Additional supportive information: Follow-up would not possible, as no contact, details were available.; Sender's Comments:  US-GSK-US2023AMR003429:same reporter - 1st dose
Information has been received from a physician concerning a 4 month old male who in August 2007, was vaccinated with his first oral dose of Rotateq (No lot number was given). In August 2007, the patient developed urticaria a day or so after vaccination. Concomitant unspecified vaccinations were administered within the same visit. Unspecified medical attention was sought. It was noted that the physician was planning on discontinuing Rotateq. There was no product quality complaint. Additional information has been requested.
Headache, 101.9 temperature, chills, body aches. Fever lasted 2 days, body aches 3 days, body aches 4 days, headache 2 days, chills 2 days, fatigue lasted a week
30 min post vaccine, patient came back in with hives on left shoulder.  She received her vaccine in the left arm.  She denied any allergies.  25 mg Benadryl given in clinic, patient's symptoms improved in 10-15 min.
Severe stomach ache; muscle and joint aches and pains; Chilblains; muscle and joint aches and pains; nausea; fever; injection site pain; Vertigo; vomiting; This is a spontaneous report from a contactable consumer (patient). A 65-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Batch/Lot Number: EN6200) via an unspecified route of administration, administered in left arm on 03Mar2021 at 03:00 PM (at the age of 65 years old) as single dose, for COVID-19 immunisation. The patient's medical history included hypothyroidism, MZ on Serpina1 (as reported) and known allergies to shrimp. The patient had no COVID prior vaccination and she was not tested for COVID post-vaccination. The patient also did not receive other vaccine in four weeks. Concomitant medications included levothyroxine, thyroid (ARMOUR THYROID) and ibuprofen (ADVIL); all were taken for an unspecified indications, start and stop dates were not reported. On 03Mar2021 at 11:00 PM, it was reported that the patient experienced severe stomachache with nausea and vomiting about 12 hours post injection (as reported). She also experienced chilblains, fever, muscle and joint aches, injection site pain 8 hours post injection and vertigo. The patient did not received treatment for the adverse events. The outcome of the events was not recovered.
A sharp increase in ear ringing commenced approximately 30 hours post Novavax vaccine. The pitch of the sound is very high. The ear ringing continues unabated and is mostly on the left.  I was vaccinated in my left arm.  ? Nauseous all the time which worsens after I eat anything. Even water makes me nauseous.  ? Chronically hot and dehydrated. I am always thirsty. ? Bad headache the day after the shot and headaches continue off and on. ? Chronic fatigue  ? Chronic sleeplessness ? I am lucky if I sleep 4-5 hours a night since the shot ? Bouts of head pressure on and off. ? Dizziness at times ? Migraines - it feels like I always have a migraine ? A lot of hair loss  ? September 8, 2022  Bad headache.  Fluttering in my ears commenced and pressure changes. The pressure changes in my ears are different than the pressure I feel in my head.
Pt with history of MS has fever, tachycardia, and upper respiratory congestion.  She has been more lethargic and has coarse lung sounds.  Pt admitted due to symptoms and COVID positivity.
SYSTEMIC URTICARIAL RASH A FEW HOURS AFTER PREVNAR AND PEDIARIX VACCINES.